Motor Fluctuations in Parkinson s
|
|
|
- Anabel Charles
- 9 years ago
- Views:
Transcription
1 Motor Fluctuations in Parkinson s What are motor fluctuations? Motor fluctuations are associated with longterm use of levodopa (trade names Sinemet or Madopar, Co-careldopa or Co-beneldopa), and usually occur in people who have had Parkinson s disease for some time. The term motor fluctuations means that after a number of years of levodopa treatment, people may find that the smooth and even control of symptoms that their drugs once gave them is no longer dependable. When motor fluctuations occur, people initially find that the effects of their regular dose do not seem to last until the next dose is due (this is known as end-of-dose deterioration or, more simply, early wearing-off ). As Parkinson s progresses, people may find that their symptoms can reappear quickly and unexpectedly, a sensation that some have described as being like a light switch being turned on and off (this is known as the on/off syndrome). Some people find that they start to develop involuntary fidgety movements, which occur initially when the level of levodopa in the bloodstream is at its peak, but may appear at any time later on (these are known as dyskinesias ). Why do they occur? On/off swings are likely to be caused by an interaction between the Parkinson s itself and the drug treatment. They cannot be simply attributed to the levodopa alone, since fluctuations and involuntary movements rarely occur in people who are not taking levodopa and are not experienced by people taking levodopa who do not have Parkinson s. The best explanation for these complications is that as dopamine-producing cells in the brain are gradually lost in Parkinson s, the remaining cells must work overtime to compensate for the dopamine loss. As Parkinson s progresses, and more cells are lost, their capacity to produce dopamine, even with the help of levodopa, is exhausted more quickly (this would explain early wearingoff ). The brain attempts to compensate for the shortage of dopamine by becoming more sensitive to smaller dopamine levels. When levels of dopamine are increased temporarily by taking levodopa, this has the effect of overstimulating the part of the brain concerned with motor control, and involuntary movement results (this would explain dyskinesias). The explanation of on/off swings is more complicated. In the early stages of Parkinson s, off periods appear to be related to early wearing-off, as they occur before the next dose of levodopa is due. However, as Parkinson s progresses, on/off fluctuations become less closely related to the timing of the levodopa dose, and more unpredictable. It is thought that these fluctuations are related to other processes in the brain, and are sensitive to other factors as well as to medication. This second type of on/off fluctuation is more difficult to manage. Because they are related to levodopa treatment, motor fluctuations can be difficult to treat reducing the dose of levodopa might mean less fluctuation, but it can also mean the return of other symptoms, such as tremor, rigidity or slowness of movement. The remainder of this information sheet describes Contact the Parkinson s Disease Society freephone helpline for advice and information on
2 the three most common motor fluctuations early wearing-off, the on/off phenomenon, and dyskinesias and methods that can be used to treat these fluctuations while maintaining good control over symptoms. by tricking the brain into thinking it is receiving dopamine, rather than requiring the brain cells to work overtime to produce extra dopamine from levodopa. They may help to smooth out some of the fluctuations. What is early wearing-off? After some years of treatment, people with Parkinson s can often begin to feel the effect of each dose of levodopa they can tell when it begins to work, and when the effect on their symptoms begins to diminish or wear off. This effect starts gradually, and may begin with someone experiencing some return of their Parkinson s symptoms in the morning, before their first dose of the day. Later on, they may begin to feel this effect during the course of their daily drug regimen. How is early wearing-off treated? Because early wearing-off is related to drug treatment, the most effective ways of dealing with its effects are also drug related. As this might mean a change or addition to your drug regimen, it should be discussed with your GP or Parkinson s specialist. Keep the total daily levodopa dose at the same level, but take smaller doses more frequently. It may be useful to change to one of the controlled-release forms of levodopa (trade names Sinemet CR or Madopar CR). These can help to keep the drug levels in the bloodstream constant, and can prolong the time needed between doses by 30 to 50%. Your doctor may suggest adding a dopamine agonist drug to your regime (for example bromocriptine, lisuride, pergolide, ropinirole, cabergoline or pramipexole). These drugs work Your doctor may suggest adding a drug called entacapone (Comtess) to your regime. Entacapone slows the breakdown of levodopa by the body, prolonging its duration of action. Recently, a stronger and more effective alternative to entacapone, tolcapone (Tasmar), has been re-introduced in the UK. This drug is potentially dangerous for some people, and those who use it require regular blood tests to ensure they do not develop liver damage. Your Parkinson s specialist will be able to advise you about this. Another drug called selegiline (Eldepryl) may be suggested by your doctor. Selegiline slows the breakdown of dopamine in the brain, and can be used to prolong the effectiveness of the levodopa dose. For more information on any of these drugs, see the booklet the Drug Treatment of Parkinson s disease. In some people, protein in the diet can interfere with the absorption of levodopa into the bloodstream. It may be useful to try a protein redistribution diet, where most of the daily protein intake is restricted to the evening hours. This can help the levodopa treatment to be more effective in the daytime, when you are likely to need it more. However, as protein is essential for a healthy diet, you should not reduce the amount of protein you consume. The effect of such dietary manipulation is usually small, and you should discuss protein redistribution with a state registered dietician or with your GP or Parkinson s specialist before you try it. Contact the Parkinson s Disease Society freephone helpline for advice and information on
3 For more information, see the booklet Parkinson s and Diet. What is the on/off syndrome? The on/off syndrome can best be described as an unpredictable shift from relative wellness to move going off, although off to on can occur just as suddenly. The speed of this shift can be so dramatic that some people have likened this effect to a light switch being turned on and off, and others use the term yo-yoing to describe it. On/off fluctuations are different from the phenomenon known as freezing, which can also affect people who have had Parkinson s for some time. Freezing is the word used to describe the experience of stopping suddenly while walking, or when beginning to initiate walking, and being unable to move forward again for several seconds or minutes. People feel as though their feet are frozen or stuck to the ground, but that the top half of their body still wants to move on. While freezing episodes tend to last only a few seconds, on/off fluctuations can continue for minutes, or even hours. It is also thought that different processes of the brain are involved for each phenomenon. For more information, see the information sheet Freezing in Parkinson s. On/off effects do not just affect a person s mobility, however. They are often accompanied by changes in other symptoms, such as an increase in anxiety, visual disturbances, sweating or, sometimes, pain in the limbs. Some people can find on/off fluctuations very distressing, especially as they can happen suddenly and unexpectedly. Other people are able to judge in advance when an episode is likely to occur. How is the on/off syndrome treated? Many of the strategies that can be used to treat wearing-off effects can also be tried when someone is experiencing on/off fluctuations, such as increasing the frequency of dosage, changing to a controlled-release preparation of levodopa, or adding other drugs such as a dopamine agonist, entacapone (Comtess), or selegiline (Eldepryl). Effective treatment of the on/off syndrome can sometimes be difficult. Some other treatments can help: It can sometimes help to take an extra dose of levodopa treatment, although this can often be ineffective and should be discussed with a medical professional. If it doesn t work, a dispersible preparation of levodopa, which is absorbed more quickly than standard levodopa tablets, may be more effective, producing a more rapid surge in the blood level of levodopa than a controlled-release preparation. Alternatively, some people have found benefit from the drug apomorphine (APO-go), which is a dopamine agonist given by injection under the skin. This drug does not always help, but it is sometimes tried with people who have frequent off periods of half an hour or more and who have not improved after adjustments to their ordinary medication. The main advantage of apomorphine is that it can act as a rescue treatment when tablets or capsules fail to take effect. For people who are assessed as suitable, it will work within 5 to 15 minutes much more quickly than tablets or capsules. The effect of each injection is short, usually about 45 minutes, but may tide someone over until they come on again. Because of this predictable response, it can sometimes help people with Parkinson s who are in employment Contact the Parkinson s Disease Society freephone helpline for advice and information on
4 to go on working for longer than would otherwise be possible. For more information, see the information sheet Apomorphine. involuntary movements can be more upsetting to an observer than to the person actually experiencing them. What are dyskinesias? Dyskinesia is a medical term for movements, other than tremor, that are not intended or willed by the person concerned. These involuntary fidgety movements can include twitches, jerks, twisting or writhing movements, or simple restlessness. The exact cause of dyskinesias is unknown, but they seem to be connected to the excessive dopaminergic stimulation brought about by levodopa treatment. Like early wearing-off and the on/ off syndrome, it is assumed that they are the result of a combination of levodopa treatment and the progression of Parkinson s. It has been suggested that dyskinesias may be the result of the brain s attempts to compensate for the loss of dopamine in Parkinson s. One way that the brain might do this is to increase the sensitivity of its brain cells to dopamine, so that a smaller amount can bring about the same response. The brain cells that respond to dopamine may then become supersensitive. Alternatively, it may be that over time, other cells that do not normally respond to levodopa begin to convert it to dopamine, but may release it at the wrong time, or to the wrong parts of the body. Dyskinesias can appear in different forms, and their frequency and timing can differ from person to person. Some people can have dyskinesias for most of the day, but for others they may only appear after taking a tablet, or just before the next is due. Also, some people may barely notice their dyskinesias, while for others they may be a source of great concern. Often, What kinds of dyskinesia are there? Dyskinesias can affect various parts of the body, but often involve the limbs and trunk. They can take the form of rapid, dance-like movements known as chorea or choreiform movements. Some people have said that chorea is almost the opposite of their Parkinson s symptoms, since instead of rigid muscles and slowness of movement, the person will have loose and floppy muscles, and too much movement. Other people may experience what is known as dystonia, a sustained involuntary contraction of the muscles, causing the affected part of the body to go into a spasm. Dystonia can also occur as a separate condition in itself, but it can often be associated with a number of other conditions, including Parkinson s. In such cases, it is often referred to as secondary or symptomatic dystonia, and is often, but not always, related to the timing of the anti- Parkinson s medication. For more information on dystonia, see the information sheet Muscle Cramps and Dystonias. The timing of dyskinesias can also vary greatly between individuals. The most common form can be found when the dose of levodopa is reaching the peak of its effectiveness, and brain dopamine levels are at their highest; this is known as peak-dose dyskinesia. Much less commonly, dyskinesia can occur both when the dose of medication is beginning to take effect, and when the effects begin to wear-off. This is known as diphasic or the dyskinesiaimprovement-dyskinesia pattern. This can appear as a combination of chorea and Contact the Parkinson s Disease Society freephone helpline for advice and information on
5 dystonia, and can be more difficult to treat than peak-dose dyskinesia. How can dyskinesia be treated? Dyskinesia can be difficult to treat. Because it appears as a result of the build-up of an increased sensitivity to dopamine levels in the brain, the first option would be to reduce the amount of levodopa treatment. However, as this approach could lead to the return of Parkinson s symptoms such as tremor, rigidity or slowness of movement, and could also mean more early wearing-off or on/off effects, this is not always possible. Usually, if people are having trouble with dyskinesias, they will seek to find a balance between better mobility and involuntary movements. Other approaches may be useful. As always, these should be discussed with your doctor or Parkinson s specialist: It may help the person to switch to a controlled-release preparation of levodopa, as these produce lower peak concentrations of brain dopamine. This might help to smooth out the response to the treatment, resulting in less dyskinesia. It is often helpful to maximise the dose of dopamine agonist drug a person is taking, and reduce the levodopa to the minimum they can tolerate. Some people may benefit from switching from one dopamine agonist drug to another. The drug amantadine (Symmetrel) can sometimes help dyskinesias. Amantadine promotes the release of dopamine in the brain, and allows it to stay longer at its site of action. Unfortunately, it only works for a minority of people, its effectiveness is generally mild and may be short lived. Can surgery help with fluctuations and dyskinesias? Surgery is not suitable for everyone, but it is generally used to treat people who have had Parkinson s for some time and who are finding that their symptoms are no longer controlled effectively by medication and/ or they are experiencing very troublesome dyskinesias. In particular, lesioning techniques (e.g. pallidotomy, thalamotomy) and deep brain stimulation have been used with some success in controlling motor fluctuations. Each form of surgery for Parkinson s carries risks, however, and should be discussed with your Parkinson s specialist. For more information on surgical techniques, see the publication Surgery and Parkinson s disease. What can I do myself? There is some evidence that the chances of developing these complications of Parkinson s are reduced by taking dopamine agonists at reasonable doses from early on in treatment. When people begin to experience wearing-off and on/off fluctuations, it is important that their regime be managed to maximise on time. This becomes much more complicated if a person also begins to experience dyskinesias, as they then have to decide on a compromise between more on time with dyskinesias, or more off time with other Parkinson s symptoms. Many people tend to prefer more on time, even with the dyskinesias, but this will vary between individuals and you should discuss this issue with your GP or Parkinson s specialist. Contact the Parkinson s Disease Society freephone helpline for advice and information on
6 To maximise on time with the least possible dyskinesia, it can be helpful for the the person with Parkinson s or their carer to complete a 24-hour diary, where they can indicate the times and frequency of their symptoms and fluctuations, along with the times and frequency of their dosage. This can help both you and your Parkinson s specialist to understand your response to medication, and the proportion of the day that you are experiencing difficulties. It can also provide a better idea of the most useful strategies to try and smooth out the fluctuations. A sample diary, and suggestions on how to use it, are included in the information sheet Keeping a Diary: For People with Parkinson s. There is also a separate sheet Keeping a Diary: For Carers. Further information More information on the drugs mentioned in this information sheet is available in the booklet the Drug Treatment of Parkinson s disease. Information and advice are also available from the PDS Helpline, which you can call on Text Relay: (for textphone users only), Monday to Friday, 9am to 8pm (except bank holidays), Saturdays, 10am to 2 pm, or [email protected] Acknowledgements The PDS would like to thank Dr Richard Grünewald for reviewing this information sheet. Using the record of your fluctuations can help you work with your doctor to get the best effects from your medication. Fluctuations can be difficult to treat, and people can differ over how they want them managed. It is important to get the right balance for you, to ensure that you have the best quality of life possible. Parkinson s Disease Society 215 Vauxhall Bridge Road, London SW1V 1EJ, UK Tel: Fax: Helpline: Text Relay: (for textphone users only) (The Helpline is a confidential service. Calls are free from UK landlines and some mobile networks) [email protected] Website: Parkinson s Disease Society of the United Kingdom (2008) Charity registered in England and Wales No and in Scotland No. SC A company limited by guarantee. Registered No (London) Registered office: 215 Vauxhall Bridge Road, London SW1V 1EJ Revised November 2008 To obtain any resource, please go online to or contact Sharward Services Ltd, the appointed Distribution House, at Westerfield Business Centre, Main Road, Westerfield, Ipswich, Suffolk IP6 9AB Tel: Fax: [email protected] Contact the Parkinson s Disease Society freephone helpline for advice and information on Code FS73
If you have been taking a Parkinson s drug that contains levodopa,
Symptoms and lifestyle Wearing off and involuntary movements (dyskinesia) If you have been taking a Parkinson s drug that contains levodopa, for example co-beneldopa or co-careldopa, for some time, you
Keeping a Diary: For Carers
Keeping a Diary: For Carers If you are a carer, it can be very useful to keep a weekly or monthly diary to record how you cope with caring, the tasks that you do and anything that you find particularly
Coenzyme Q10. Information Sheet
Coenzyme Q10 What is Coenzyme Q10? Coenzyme Q10 (or CoQ10) is a substance present in every cell of the body. A coenzyme is a very small molecule that enhances the function of enzymes, particularly in the
CENTRAL NERVOUS SYSTEM MANAGEMENT OF PARKINSON S DISEASE
MANAGEMENT CENTRAL NERVOUS SYSTEM MANAGEMENT OF PARKINSON S DISEASE Parkinson s Disease is classically determined by the triad or rest tremor (usually starting in one arm) with bradykinesia (slowing of
a quick introduction to parkinson s
a quick introduction to parkinson s if you have just been diagnosed or know somebody who has, you ve probably got a lot of questions and perhaps some worries. That s where Parkinson s UK can help. We re
Doncaster & Bassetlaw Medicines Formulary
Doncaster & Bassetlaw Medicines Formulary Section 4.9: Drugs Used in Parkinsonism and related Disorders Co-Beneldopa 12.5/50, 25/100 and 50/200 (Madopar) Capsules Co-Beneldopa 12.5/50 and 25/100 Dispersible
Acute management of Parkinson s
Acute management of Parkinson s Fife Parkinson s Service 2013 1 Contents 1. Introduction 2. On admission to hospital 3. If Patient has compromised swallow or is nil by mouth 4. Conversion charts if patient
Parkinson's s disease - a
Parkinson's Disease Parkinson's s disease - a progressive disorder of the nervous system that affects movement. The most common perception of Parkinson s is the patient having tremors. Hands shaking, inability
Current evidence suggests that Parkinson s tends to develop
About Parkinson's Diagnosing Parkinson s Current evidence suggests that Parkinson s tends to develop gradually and it may be many months, even years, before the symptoms become obvious enough for you to
SLEEP DIFFICULTIES AND PARKINSON S DISEASE Julie H. Carter, R.N., M.S., A.N.P.
SLEEP DIFFICULTIES AND PARKINSON S DISEASE Julie H. Carter, R.N., M.S., A.N.P. Problems with sleep are common in Parkinson s disease. They can sometimes interfere with quality of life. It is helpful to
drug treatments for parkinson s
drug treatments for parkinson s While there is no cure yet for Parkinson s, there are many different drugs that can help manage the symptoms. This booklet is for people with Parkinson s and their families.
SLEEP AND PARKINSON S DISEASE
A Practical Guide on SLEEP AND PARKINSON S DISEASE MICHAELJFOX.ORG Introduction Many people with Parkinson s disease (PD) have trouble falling asleep or staying asleep at night. Some sleep problems are
drug treatments for parkinson s
drug treatments for parkinson s 1 While there is no cure yet for Parkinson s, there are many different drugs that can help manage the symptoms. This booklet is for people with Parkinson s and their families.
Management of Parkinson s Disease in Primary Care
Management of Parkinson s Disease in Primary Care Dr June Tan National University Hospital System (NUHS) Division of Neurology Senior Consultant Topics: Diagnosing PD Choice of medication in the de novo
Treatment of colon cancer
Treatment of colon cancer This information is an extract from the booklet, Understanding colon cancer. You may find the full booklet helpful. We can send you a copy free see page 5. Contents How treatment
Lewy body dementia Referral for a Diagnosis
THE Lewy Body society The more people who know, the fewer people who suffer Lewy body dementia Referral for a Diagnosis Lewy Body Dementias REFERRAL FOR A DIAGNOSIS In the UK people with all forms of dementia
Personal Health Record
Personal Health Record Contents Section 1: Personal details (pages 4 6) Within this section you can note all information about you, next of kin, important health information and general medical history.
Parkinson s Disease - A Junior Doctor s Survival Guide
Parkinson s Disease - A Junior Doctor s Survival Guide Professor Richard Walker Consultant Geriatrician Hon. Professor of Ageing & Interna
GLOSSARY OF TERMS. This glossary explains the terms and words often used in association with Parkinson s.
Antagonist This glossary explains the terms and words often used in association with Parkinson s. Medications which have a negative effect on particular cells in the body. In Parkinson s dopamine antagonists
PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS
PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS De Anna Looper, RN CHPN Corporate Clinical Consultant / Legal Nurse Consultant Carrefour Associates L.L.C. PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS
Stem cell research and Parkinson's
Parkinson's research Stem cell research and Parkinson's T his information sheet looks at what stem cells are and why they are important for research into a cure for Parkinson s. It also discusses where
Clinical Psychopharmacology
Clinical Psychopharmacology Antiparkinsonian drugs Department of Pharmacy, GGZ WNB Chair on Pharmacotherapy in Psychiatric Patients/Anton Loonen May 2015 2 Basal ganglia diseases Parkinson s disease and
Dementia with Lewy bodies
IS 18 April 2011 Information sheet Dementia with Lewy bodies Introduction... 1 Key points... 1 What is dementia with Lewy bodies?... 1 How many people are affected by DLB?.. 2 What is the cause?... 2 Symptoms...
ABC s of Parkinson s Disease 4/29/15 Karen Parenti, MS, PsyD
ABC s of Parkinson s Disease 4/29/15 Karen Parenti, MS, PsyD What is Parkinson s Disease? Parkinson's disease is a progressive disorder of the nervous system that affects movement. It develops gradually,
If you have Parkinson s, or care for someone who does, you may have
Work, Symptoms money and and practical lifestyle matters Income Support If you have Parkinson s, or care for someone who does, you may have some concerns about how you will manage financially. There is
PARKINSON S DISEASE INTRODUCTION. Parkinson s disease is defined as a disease of the nervous system that affects voluntary movement.
PARKINSON S DISEASE INTRODUCTION Parkinson s disease is a disorder of the brain and the nervous system. It is one of the more common neurological diseases in people over the age of 60, and it is more common
Dementia & Movement Disorders
Dementia & Movement Disorders A/Prof Michael Davis Geriatrician ACT Health & GSAHS ANU Medical School Eastern Dementia Network Aged and Dementia Care Symposium Bateman s Bay, 22 October 2010 Types of Dementia
Emergency management of patients with Parkinson s
Emergency management of patients with Parkinson s Missing doses of Parkinson s medication increases care needs and can cause serious complications, including rare but potentially fatal neuroleptic-like
What is vascular dementia?
alzheimers.org.uk What is vascular dementia? Vascular dementia is the second most common form of dementia after Alzheimer s disease. It is caused by problems in the supply of blood to the brain. This factsheet
PARKINSON'S DISEASE The Disorder and Current Therapy Copyright 2008, Daniel Kassicieh, D.O.
PARKINSON'S DISEASE The Disorder and Current Therapy Copyright 2008, Daniel Kassicieh, D.O. Parkinson's disease is a common neurologic disorder. It affects people of all ages and ethnic backgrounds and
Effect of breast cancer treatment
Effect of breast cancer treatment on the bones 1 Effect of breast cancer treatment on the bones This information is from the booklet Managing the late effects of breast cancer treatment. You may find the
Types of surgery for kidney cancer
Useful information for cancer patients Contents This information is about the different operations that you may have for kidney cancer. Surgery can be used to treat almost any stage of kidney cancer. There
What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician
What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician Overview of presentation Case history Video example pre and post treatment Historical review PD in the UK Epidemiology and aetiology Making
Chemotherapy for pancreatic
Chemotherapy for pancreatic cancer 1 Chemotherapy for pancreatic cancer This information is from the booklet Understanding pancreatic cancer. You may find the full booklet helpful. We can send you a free
Multiple System Atrophy guide (http://www.msaweb.co.uk/msaguide.htm)
Multiple System Atrophy guide (http://www.msaweb.co.uk/msaguide.htm) Accessing information on Multiple System Atrophy (MSA) can be hard work. The Sarah Matheson Trust (SMT) produces a guide to MSA that
Parkinson s Disease Symptoms Guide
Parkinson s Disease Symptoms Guide Some symptoms of Parkinson s disease (PD) are hard for even specialists to detect. Others are obvious even to an untrained eye. Parkinson s symptoms are different for
Parkinson's disease. Definition. Symptoms
Parkinson's disease Definition Parkinson's disease is a progressive disorder of the nervous system that affects your movement. It develops gradually, sometimes starting with a barely noticeable tremor
Guide to Deep Brain Stimulation Therapy
Parkinson s Disease: Guide to Deep Brain Stimulation Therapy By: Michael S. Okun, MD Medical Director, National Parkinson Foundation Center of Excellence Co-Director, Center for Movement Disorders and
University College Hospital. Hormone therapy for prostate cancer. Radiotherapy Department Patient information series
University College Hospital Hormone therapy for prostate cancer Radiotherapy Department Patient information series 10 2 If you need a large print, audio or translated copy of the document, please contact
Anti-Parkinsonism Drugs
Anti-Parkinsonism Drugs Pharma Team 429 Fahad Alrumaih Ibrahim Alshiddi Sultan Alsalem Ismail Raslan Suhail Asiri Parkinsonism - Could be: primary [idiopathic] or secondary [viral infection or drug induced
Raising Concerns or Complaints about NHS services
Raising Concerns or Complaints about NHS services Raising concerns and complaints A step by step guide Raising concerns and complaints Questions to ask yourself: 1. What am I concerned or dissatisfied
Opioids in Palliative Care- Patient Information Manual
Version 2.0 with MST example Introduction The following pages explain what opioids are and what we think you may want to know about them. There is quite a lot of information here, most of it is based on
Electroconvulsive Therapy - ECT
Electroconvulsive Therapy - ECT Introduction Electroconvulsive therapy, or ECT, is a safe and effective treatment that may reduce symptoms related to depression or mental illness. During ECT, certain parts
BREAST CANCER. How to spot the signs and symptoms and reduce your risk. cruk.org
BREAST CANCER How to spot the signs and symptoms and reduce your risk cruk.org Breast cancer is the most common cancer in the UK. Around 8 in 10 breast cancer cases are in women aged 50 and over. Men can
swine flu vaccination:
swine flu vaccination: what you need to know Flu. Protect yourself and others. Contents What is swine flu?............... 3 About the swine flu vaccine....... 4 What else do I need to know?...... 8 What
FROZEN SHOULDER OXFORD SHOULDER & ELBOW CLINIC INFORMATION FOR YOU. Frozen Shoulder FROZEN SHOULDER
OXFORD SHOULDER & ELBOW CLINIC INFORMATION FOR YOU Frozen Shoulder The aim of this information sheet is to give you some understanding of the problem you may have with your shoulder. It has been divided
Pallidotomy and Thalamotomy
Pallidotomy and Thalamotomy Vancouver General Hospital 899 West 12th Avenue Vancouver BC V5Z 1M9 Tel: 604-875-4111 This booklet will provide information about the following surgical procedures: Pallidotomy
What You Need to Know About Xenazine
Note to Healthcare Professionals: Please provide this guide to your patient or your patient s caregiver. What You Need to Know About Xenazine (tetrabenazine) Patient/Caregiver Counseling Guide This guide
1: Motor neurone disease (MND)
1: Motor neurone disease (MND) This section provides basic facts about motor neurone disease (MND) and its diagnosis. The following information is an extracted section from our full guide Living with motor
Disordered sleep at night has long been
Neurology 59 Excessive daytime sleepiness in PD Excessive Daytime Sleepiness (EDS) in Parkinson s disease (PD) is an important issue that warrants serious attention because it can have adverse effects
After pelvic radiotherapy
After pelvic radiotherapy in women 1 After pelvic radiotherapy in women This information is from the booklet Pelvic radiotherapy in women managing side effects during treatment. You may find the full booklet
Unmet Needs for Parkinson s Disease Therapeutics
Unmet Needs for Parkinson s Disease Therapeutics Coalition Against Major Diseases & FDA Workshop October 20, 2014 Caroline M Tanner MD, PhD Director, Parkinson's Disease Research Education and Clinical
STROKE SERIES SS10. Understanding thrombolysis treatment For stroke
STROKE SERIES SS10 Understanding thrombolysis treatment For stroke Chest Heart & Stroke Scotland improves the quality of life for people in Scotland affected by chest, heart and stroke illness, through
What is DIABETES? Gwen Hall Diabetes Specialist Nurse, Community Diabetes Services Portsmouth, Primary Care Team.
What is DIABETES? By: Gwen Hall Diabetes Specialist Nurse, Community Diabetes Services Portsmouth, Primary Care Team. WHAT IS DIABETES? What is diabetes? In simple terms diabetes prevents your body converting
Memantine (Ebixa) Drug treatment for Alzheimer s disease
IS 20 October 2011 Information sheet Memantine (Ebixa) Drug treatment for Alzheimer s disease Introduction... 1 How does Ebixa work?... 1 Who might benefit?... 2 What effect might Ebixa have?... 2 How
How To Treat Aphasic Depression
Antipsychotic Use in Patients with Parkinson s Disease 단국의대 정신과 이석범 Difficulties in Parkinson's disease Motor symptoms Neuropsychiatric syndromes Severe Disability Cognitive impairment 2 Neuropsychiatric
Diabetes and exercise
Diabetes and exercise Summary Symptoms of hypoglycaemia are caused by low blood sugar. Hypoglycaemia can occur if you take your diabetes medication and then do not eat enough or exercise more than usual.
If you have Parkinson s, or care for someone who does, you may have
Work, Symptoms money and and practical lifestyle matters General information about benefits If you have Parkinson s, or care for someone who does, you may have some concerns about how you will manage financially.
NEW PATIENT CLINICAL INFORMATION FORM. Booth Gardner Parkinson s Care & Movement Disorders Center Evergreen Neuroscience Institute
NEW PATIENT CLINICAL INFORMATION FORM Booth Gardner Parkinson s Care & Movement Disorders Center Evergreen Neuroscience Institute Date: Name: Referring Doctor: How did you hear about us? NWPF Your Physician:
A guide for adults with. Intestinal. Dysmotility
A guide for adults with Intestinal Dysmotility This leaflet contains information for patients with dysmotility of the gut and discusses symptoms and management. page 2 Contents Introduction 4 Symptoms
Surgery for oesophageal cancer
Surgery for oesophageal cancer This information is an extract from the booklet Understanding oesophageal cancer (cancer of the gullet). You may find the full booklet helpful. We can send you a free copy
Galantamine hydrobromide (Reminyl) Drug treatment for Alzheimer s disease
IS 17 October 2011 Information sheet Galantamine hydrobromide (Reminyl) Drug treatment for Alzheimer s disease Introduction... 1 How does Reminyl work?... 1 Who might benefit?... 2 What effect might Reminyl
The majority of parkinsonism (approx. 80%) is due to idiopathic PD other causes include drug therapy (Table 1),toxins and trauma.
THE TREATMENT OF PARKINSON S DISEASE SUMMARY Levodopa (L-dopa) administered in conjunction with a dopa decarboxylase inhibitor (DDCI) remains the mainstay of therapy for Parkinson s disease. New drugs
The faecal occult blood (FOB) test
The faecal occult blood (FOB) test This information is an extract from the booklet, Understanding bowel cancer screening. You may find the full booklet helpful. We can send you a copy free see page 6.
Alzheimer s and memory loss
Alzheimer s and memory loss Introduction This introductory leaflet aims to help you understand about memory loss, Alzheimer s disease and other forms of dementia. You can also find out how to get more
Making a complaint. The difference between making a complaint and clinical negligence
Macmillan and Cancerbackup have merged. Together we provide free, high quality information for all. Making a complaint This fact sheet is for people who want to make a complaint because they re unhappy
Coping with chemotherapy
This information is an extract from the booklet Understanding chemotherapy. You may find the full booklet helpful. We can send you a copy free see page 11. Contents Feelings and emotions How you can help
The Radiotherapy Department Radiotherapy to the chest wall and lymph nodes
Oxford University Hospitals NHS Trust The Radiotherapy Department Radiotherapy to the chest wall and lymph nodes Information for patients Introduction This leaflet is for people who have had surgery for
1. What are anti-epileptic drugs? Anti-epileptic drugs (AEDs) are prescribed to control seizures. They do not cure epilepsy.
14 FREQUENTLY ASKED QUESTIONS ON ANTI- EPILEPTIC DRUGS 1. What are anti-epileptic drugs? Anti-epileptic drugs (AEDs) are prescribed to control seizures. They do not cure epilepsy. 2. When should treatment
Causes, incidence, and risk factors
Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,
Parkinson Disease Levodopa-Induced Dyskinesia. Christopher Kenney, MD Novartis Pharmaceuticals
Parkinson Disease Levodopa-Induced Dyskinesia Christopher Kenney, MD Novartis Pharmaceuticals Disclosures Dr. Kenney is a full-time employee of Novartis Pharmaceuticals Corporation The opinions expressed
Contents. Overview. Removing the womb (hysterectomy) Overview
This information is an extract from the booklet Understanding womb (endometrial) cancer. You may find the full booklet helpful. We can send you a free copy see page 9. Overview Contents Overview Removing
3 Attendance Allowance
3 Attendance Allowance Most people continue to enjoy good health well into old age. But many older people need help with daily living. You may need help with personal care, such as dressing, washing or
Department of Neurosciences Dorsal Root Ganglion (DRG) Stimulation Information for patients
Oxford University Hospitals NHS Trust Department of Neurosciences Dorsal Root Ganglion (DRG) Stimulation Information for patients We have recently seen you in clinic as you have had pain for a long period
Radioactive iodine treatment for thyroid cancer
Radioactive iodine treatment for thyroid cancer This information is an extract from the booklet, Understanding thyroid cancer. You may find the full booklet helpful. We can send you a copy free see page
If you have Parkinson s, you may find that you are struggling to pay
Work, money and practical matters Help with Council Tax If you have Parkinson s, you may find that you are struggling to pay your Council Tax. But there is some financial support available, so it s important
Understanding Clinical Trials
Understanding Clinical Trials The UK Clinical Research Collaboration (UKCRC) is a partnership of organisations working to establish the UK as a world leader in clinical research, by harnessing the power
Complex regional pain syndrome and osteoporosis
Complex regional pain syndrome and osteoporosis What is osteoporosis? Osteoporosis literally means porous bones. It occurs when the struts which make up the mesh-like structure within bones become thin
